PCOS EL-PFDD Meeting
I had the pleasure of co moderating the first ever “ The Polycystic Ovary Syndrome Externally-Led Patient-Focused Drug Development (PCOS EL-PFDD) Meeting Presented by PCOS Challenge . The externally-led Patient-Focused Drug Development meetings give the US Food and Drug Administration (FDA) and other key stakeholders, including medical product developers, healthcare providers, and federal partners, an important opportunity to hear directly from patients, their families, caregivers, and patient advocates about the symptoms that matter most to them, the impact the disease has on patients’ daily lives, and patients’ experiences with currently available treatments.
